financetom
Business
financetom
/
Business
/
Marimaca Copper Secures Option to Buy Madrugador Project in Chile
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Marimaca Copper Secures Option to Buy Madrugador Project in Chile
Dec 17, 2024 5:01 AM

07:32 AM EST, 12/17/2024 (MT Newswires) -- Marimaca Copper ( MARIF ) said Tuesday that it signed a binding option agreement to acquire the Madrugador project in Chile.

The company said Madrugador is located near the Pampa Medina project, and the acquisition consolidated its ownership of the southern extent of the Sierra de Medina property package.

Under the terms, Marimaca Copper ( MARIF ) will pay US$12 million over a five-year period. The sellers will retain a 1.5% royalty on Madrugador's net gross sales. Marimaca can buy back 1.0% of the royalty for US$1.5 million.

"The acquisition of Madrugador consolidates our ownership of what we now recognize as a highly prospective district for complementary leachable copper resources, underpinning our aspirations for growth in copper production in the future," said Hayden Locke, Marimaca's president and CEO.

Marimaca's share price rose 4.1% on Monday to $4.59 on the TSX.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Johnson & Johnson Says Erleada Combination Therapy Achieves 100% BCR-Free Rate
Johnson & Johnson Says Erleada Combination Therapy Achieves 100% BCR-Free Rate
May 3, 2024
04:07 PM EDT, 05/03/2024 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Friday that its latest Phase 2 Apa-RP study on Erleada and ADT combination therapy in post-radical prostatectomy patients with high-risk localized prostate cancer showed a 100% biochemical recurrence-free rate at 24 months. The Apa-RP study, which met its primary endpoint, assessed high-risk localized prostate cancer patients...
Colgate Palmolive Insider Sold Shares Worth $579,696, According to a Recent SEC Filing
Colgate Palmolive Insider Sold Shares Worth $579,696, According to a Recent SEC Filing
May 3, 2024
04:07 PM EDT, 05/03/2024 (MT Newswires) -- John P Bilbrey, Director, on May 01, 2024, sold 6,329 shares in Colgate Palmolive ( CL ) for $579,696. Following the Form 4 filing with the SEC, Bilbrey has control over a total of 34,955 shares of the company, with 30,236 shares held directly and 4,719 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/21665/000122520824005537/xslF345X03/doc4.xml ...
Fti Consulting Insider Sold Shares Worth $9,394,746, According to a Recent SEC Filing
Fti Consulting Insider Sold Shares Worth $9,394,746, According to a Recent SEC Filing
May 3, 2024
04:07 PM EDT, 05/03/2024 (MT Newswires) -- Steven Henry Gunby, Director, President & CEO, on May 01, 2024, sold 44,113 shares in Fti Consulting ( FCN ) for $9,394,746. Following the Form 4 filing with the SEC, Gunby has control over a total of 311,297 shares of the company, with 311,297 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/887936/000088793624000069/xslF345X03/wk-form4_1714766625.xml Price: 215.14, Change:...
Colgate Palmolive Insider Sold Shares Worth $562,091, According to a Recent SEC Filing
Colgate Palmolive Insider Sold Shares Worth $562,091, According to a Recent SEC Filing
May 3, 2024
04:06 PM EDT, 05/03/2024 (MT Newswires) -- Sally Massey, Chief Human Resources Officer, on May 01, 2024, sold 6,115 shares in Colgate Palmolive ( CL ) for $562,091. Following the Form 4 filing with the SEC, Massey has control over a total of 21,668 shares of the company, with 13,924 shares held directly and 7,744 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/21665/000122520824005538/xslF345X03/doc4.xml...
Copyright 2023-2026 - www.financetom.com All Rights Reserved